Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior Laryngeal Nerve Blocks in Microdirect Laryngoscopy for Benign Vocal Fold Lesions
NCT06734975Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine, triamcinolone acetonide in voice disorder, vocal cord polyps, vocal cord cyst, sponsored by Rutgers University. Started Jul 2025; status: recruiting.
02
Drugs
bupivacainetriamcinolone acetonide
03
Conditions
voice disordervocal cord polypsvocal cord cyst
Beyond the preview
Go deeper on NCT06734975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06734975.